Corporate Corruption Media ArticlesExcerpts of Key Corporate Corruption Media Articles in Major Media
Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
U.S. farmers are using more hazardous pesticides to fight weeds and insects due largely to heavy adoption of genetically modified crop technologies that are sparking a rise of "superweeds" and hard-to-kill insects, according to a newly released study. Genetically engineered crops have led to an increase in overall pesticide use, by 404 million pounds from the time they were introduced in 1996 through 2011, according to the report by Charles Benbrook, a research professor at the Center for Sustaining Agriculture and Natural Resources at Washington State University. Of that total, herbicide use increased over the 16-year period by 527 million pounds while insecticide use decreased by 123 million pounds. Herbicide-tolerant crops were the first genetically modified crops introduced to world, rolled out by Monsanto Co. in 1996, first in "Roundup Ready" soybeans and then in corn, cotton and other crops. Roundup Ready crops are engineered through transgenic modification to tolerate dousings of Monsanto's Roundup herbicide. In recent years, more than two dozen weed species have become resistant to Roundup's chief ingredient glyphosate, causing farmers to use increasing amounts both of glyphosate and other weedkilling chemicals to try to control the so-called "superweeds." Resistant weeds have become a major problem for many farmers reliant on GE crops, and are now driving up the volume of herbicide needed each year by about 25 percent.
Note: For deeply revealing reports from reliable major media sources on the environmental and health risks posed by GMO foods, click here.
The new stealth campaign against three Florida Supreme Court justices is being backed by those meddling right-wing billionaires from Wichita, Charles and David Koch. Last week they uncorked the first of a series of commercials from their political action committee, Americans for Prosperity. The targets are Justices R. Fred Lewis, Barbara Pariente and Peggy Quince. They were three of the five-vote majority that in 2010 knocked down a half-baked amendment slapped together by state lawmakers seeking to nullify the federal Affordable Health Care Act. The Florida Supreme Court upheld lower court decisions in finding that the proposed amendment contained “misleading and ambiguous language,” the hallmark of practically everything produced by this Legislature. On the November ballot, Lewis, Pariente and Quince are up for merit retention, meaning voters can choose to retain them or not. This simple system was put in place to keep the state’s high court above the sleaze of political races. The mission of the Kochs, hiding as always behind their super PAC, is to get the three justices dumped at the polls so that Gov. Rick Scott can appoint replacements. The last thing these guys want is fair judges who know the law; they want partisan judges who’ll obediently support their political agenda. It’s worse than just trying to buy an election. It’s trying to hijack Florida’s justice system at the highest levels.
Note: For deeply revealing reports from reliable major media sources on the control of elections by corporations and rich individuals, click here.
A growing number of patients are paying directly most, or all, of their medical bills these days. One problem they face: Finding out what health care services really cost before they make the decision to buy. Even though it accounts for one-sixth of the U.S. economy, health care is difficult to shop for in all but a small percentage of health care purchases. For the most part, no one ever sees a real price for health care services - not doctors, not patients, not employers, not employees. The reason patients never see the prices is because third-party payers (insurance companies, employers and government) negotiate with providers - leaving patients with a small co-pay under traditional insurance. And without real prices, there is no basis for third-party payers or anyone to negotiate the lowest possible prices. Recently, however, more and more employers are encouraging their employees to shop for health care the way they shop for groceries. To encourage that activity, employers are allowing their employees to manage more of their own health care dollars by means of a health savings account. The idea behind an HSA is a simple one: Instead of giving all of your health dollars to an insurance company or the government, you put some of those dollars into an account that you own and control. This reduces wasteful health care spending because individuals ... spending their own money often get the lowest prices, and they also can decide whether they really want to buy those services. A recent Rand Corp. study found that patients with HSA plans reduced medical spending by about 30 percent, without adversely affecting their health.
Note: For deeply revealing reports from reliable major media sources on corporate corruption, click here.
Few countries blew up more spectacularly than Iceland in the 2008 financial crisis. The local stock market plunged 90 percent; unemployment rose ninefold; inflation shot to more than 18 percent; the country’s biggest banks all failed. Since then, Iceland has turned in a pretty impressive performance. It has repaid International Monetary Fund rescue loans ahead of schedule. Growth this year will be about 2.5 percent, better than most developed economies. Unemployment has fallen by half. Iceland’s approach was the polar opposite of the U.S. and Europe, which rescued their banks and did little to aid indebted homeowners. Nothing distinguishes Iceland as much as its aid to consumers. To homeowners with negative equity, the country offered write-offs that would wipe out debt above 110 percent of the property value. The government also provided means-tested subsidies to reduce mortgage-interest expenses: Those with lower earnings, less home equity and children were granted the most generous support. In June 2010, the nation’s Supreme Court gave debtors another break: Bank loans that were indexed to foreign currencies were declared illegal. Because the Icelandic krona plunged 80 percent during the crisis, the cost of repaying foreign debt more than doubled. The ruling let consumers repay the banks as if the loans were in krona. These policies helped consumers erase debt equal to 13 percent of Iceland’s $14 billion economy. Now, consumers have money to spend on other things.
Note: For deeply revealing reports from reliable major media sources on the collusion of most major governments with the financial sector whose profiteering contributed to the global economic crisis, click here.
Dr. Ben Goldacre is no slouch when it comes to rooting out the flaws in scientific studies, analyzing clinical trial data and recognizing when it's been manipulated or fudged. But even Goldacre has been fooled by bad science. In ... his forthcoming book, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, ... Goldacre describes how he ended up prescribing the antidepressant reboxetine to his patients based on insufficient data. The research overwhelmingly finds the drug to be ineffective, but it was still approved in the U.K. In order to get approval of the drug in Europe, the manufacturer had simply not published its negative data. Seven trials had been conducted comparing reboxetine against a placebo. Only one, conducted in 254 patients, had a neat, positive result, and that one was published in an academic journal, for doctors and researchers to read. But six more trials were conducted, in almost 10 times as many patients. All of them showed that reboxetine was no better than a dummy sugar pill. None of these trials was published. I had no idea they existed. It got worse. The trials comparing reboxetine against other drugs showed exactly the same picture: three small studies, 507 patients in total, showed that reboxetine was just as good as any other drug. They were all published. But 1,657 patients' worth of data was left unpublished, and this unpublished data showed that patients on reboxetine did worse than those on other drugs.
Note: For deeply revealing reports from reliable major media sources on pharmaceutical corruption, click here.
The doctors prescribing ... drugs don't know they don't do what they're meant to. Nor do their patients. The manufacturers know full well, but they're not telling. Negative data goes missing, for all treatments, in all areas of science. The regulators and professional bodies we would reasonably expect to stamp out such practices have failed us. Drugs are tested by the people who manufacture them, in poorly designed trials, on hopelessly small numbers of weird, unrepresentative patients, and analysed using techniques that are flawed by design, in such a way that they exaggerate the benefits of treatments. Unsurprisingly, these trials tend to produce results that favour the manufacturer. When trials throw up results that companies don't like, they are perfectly entitled to hide them from doctors and patients, so we only ever see a distorted picture of any drug's true effects. This distorted evidence is then communicated and applied in a distorted fashion. In their 40 years of practice after leaving medical school, doctors hear about what works ad hoc, from sales reps, colleagues and journals. But those colleagues can be in the pay of drug companies – often undisclosed – and the journals are, too. And so are the patient groups. And finally, academic papers, which everyone thinks of as objective, are often covertly planned and written by people who work directly for the companies, without disclosure. Sometimes whole academic journals are owned outright by one drug company.
Note: This is an edited extract from Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, by Ben Goldacre, published next week by Fourth Estate. For deeply revealing reports from reliable major media sources on pharmaceutical corruption, click here.
The global pharmaceutical industry has racked up fines of more than $11bn in the past three years for criminal wrongdoing, including withholding safety data and promoting drugs for use beyond their licensed conditions. In all, 26 companies, including eight of the 10 top players in the global industry, have been found to be acting dishonestly. The scale of the wrongdoing, revealed for the first time, has undermined public and professional trust in the industry and is holding back clinical progress, according to two papers published in today's New England Journal of Medicine. Leading lawyers have warned that the multibillion-dollar fines are not enough to change the industry's behaviour. The 26 firms are under "corporate integrity agreements", which are imposed in the US when healthcare wrongdoing is detected, and place the companies on notice for good behaviour for up to five years. The largest fine of $3bn, imposed on the UK-based company GlaxoSmith-Kline in July after it admitted three counts of criminal behaviour in the US courts, was the largest ever. But GSK is not alone – nine other companies have had fines imposed, ranging from $420m on Novartis to $2.3bn on Pfizer since 2009, totalling over $11bn. Kevin Outterson, a lawyer at Boston University, says that despite the eye watering size of the fines they amount to a small proportion of the companies' total revenues and may be regarded as a "cost of doing business".
Note: For deeply revealing reports from reliable major media sources on pharmaceutical corruption, click here.
French scientists said on [September 19] that rats fed on Monsanto's genetically modified corn or exposed to its top-selling weedkiller suffered tumors and multiple organ damage. Gilles-Eric Seralini of the University of Caen and colleagues said rats fed on a diet containing NK603 - a seed variety made tolerant to dousings of Monsanto's Roundup weedkiller - or given water with Roundup at levels permitted in the United States, died earlier than those on a standard diet. The animals on the GM diet suffered mammary tumors, as well as severe liver and kidney damage. The study was published in the peer-reviewed journal Food and Chemical Toxicology and presented at a news conference in London. The researchers said 50 percent of males and 70 percent of females died prematurely, compared with only 30 percent and 20 percent in the control group. GMOs are deeply unpopular in Europe and many other countries, but dominate key crops in the United States after Monsanto in 1996 introduced a soybean genetically altered to tolerate Monsanto's Roundup weed killer. Seralini was part of a team that has voiced previous safety concerns based on a shorter rat study in a scientific paper published in 2009. This new study takes things a step further by tracking the animals throughout their two-year lifespan. Seralini believes his latest lifetime rat tests give a more realistic and authoritative view of risks than the 90-day feeding trials that form the basis of GM crop approvals, since three months is only the equivalent of early adulthood in rats.
Note: For alarming photos and more from the above long-term study on the dangers of GM food, click here. For an incisive, powerful 13-minute video revealing the disturbing results of this first long-term scientific study on GMOs, click here. For an excellent article and a great two-minute video clearly explaining the major dangers of GM food, click here. For a powerful summary of the health risks from GM foods, click here.
It's not an exaggeration to say that almost everyone wants to see the labeling of genetically engineered materials contained in their food products. And on Nov. 6, in what's unquestionably among the most important non-national votes this year, Californians will have the opportunity to make that happen [by voting] on Proposition 37. It would require "labeling on raw or processed food offered for sale to consumers if made from plants or animals with genetic material changed in specified ways." And it would prohibit marketing "such food, or other processed food, as ‘natural.' " Polls show Prop 37 to be overwhelmingly popular: roughly 65 percent for to 20 percent against, with 15 percent undecided. Nationally, on the broader issue of labeling, in answer to the question of whether the Food and Drug Administration should require that "foods which have been genetically engineered or containing genetically engineered ingredients be labeled to indicate that," a whopping 91 percent of voters say yes and 5 percent say no. This is as nonpartisan as an issue gets, and the polls haven't changed much in the last couple of years. Unsurprisingly, Big Food in general - and particularly companies like Monsanto that produce genetically engineered seeds ... have already thrown tens of millions of dollars into defeating Prop 37. In general, as California goes, so goes the nation.
Note: With such a strong mandate, why do no U.S. states have GMO labeling laws? Will the many millions of dollars pumped into the Prop 37 campaign by Monsanto and others sway the voters? We will find out soon. For a powerful summary of the health risks from GMO foods, click here.
Federal and state authorities are investigating [several] major American banks for failing to monitor cash transactions in and out of their branches, a lapse that may have enabled drug dealers and terrorists to launder tainted money. Regulators, led by the Office of the Comptroller of the Currency, are close to taking action against JPMorgan Chase for insufficient safeguards. The agency is also scrutinizing several other Wall Street giants, including Bank of America. In addition to the comptroller, prosecutors from the Justice Department and the Manhattan district attorney’s office are investigating several financial institutions in the United States. The surge in investigations, compliance experts say, is coming now because authorities were previously inundated with problems stemming from the 2008 financial turmoil. Until now, investigators have primarily focused on financial transactions at European banks. The authorities accused several foreign banks of flouting American law by transferring billions of dollars on behalf of sanctioned nations. As the investigation shifts to American shores, the Justice Department and the Manhattan district attorney’s office are moving beyond those violations to focus on money-laundering, in which criminals around the globe try to hide illicit funds in United States bank accounts.
Note: For deeply revealing reports from reliable major media sources on financial corruption, click here.
Former President Jimmy Carter issued a blistering indictment of the U.S. electoral process ..., saying it is shot through with "financial corruption" that threatens American democracy. Carter said "we have one of the worst election processes in the world right in the United States of America, and it's almost entirely because of the excessive influx of money." The 39th president lamented a recent U.S. Supreme Court decision that allows unlimited contributions to third-party groups that don't have to disclose their donors. The dynamic is fed, Carter said, by an income tax code that exacerbates the gap between the wealthiest Americans and the rest of the electorate, allowing the rich even greater influence over public discourse and electioneering. He added that he hopes the "Supreme Court will reverse that stupid ruling," referring to the case known as Citizens United. He said the United States should return to publicly financed elections for president. The system technically is still in place, but it is voluntary and both President Barack Obama and Republican challenger Mitt Romney have chosen to bypass the taxpayer money because they can amass far more on their own. "You know how much I raised to run against Gerald Ford? Zero," Carter said, referring to his 1976 general election opponent. "You know how much I raised to run against Ronald Reagan? Zero. You know how much will be raised this year by all presidential, Senate and House campaigns? $6 billion. That's 6,000 millions."
Note: For deeply revealing reports from reliable major media sources on our dysfunctional electoral system, click here.
Attorneys for jailed former Swiss banker Bradley Birkenfeld announced [on September 11] that the IRS will pay him $104 million as a whistleblower reward for information he turned over to the US government. The information Birkenfeld revealed detailed the inner workings of the secretive private wealth management division of the Swiss bank UBS, where the American-born Birkenfeld helped his US clients evade taxes by hiding wealth overseas. Tuesday's announcement represents an astonishing turn of fortune for Birkenfeld, who was released from federal prison in August after serving 31 months on charges relating to his efforts to help a wealthy client avoid taxes. Birkenfeld attorney Stephen Kohn said the information the former Swiss banker turned over to the IRS led directly to the $780 million fine paid to the US by his former employer, UBS, as well as leading over 35,000 taxpayers to participate in amnesty programs to voluntarily repatriate their illegal offshore accounts. That resulted in the collection of over $5 billion dollars in back taxes, fines and penalties that otherwise would have remained outside the reach of the government. Birkenfeld's disclosures also led to the first cracks in the legendarily secretive Swiss banking system, and ultimately the Swiss government changed its tax treaty with the United States. UBS turned over the names of more than than 4,900 U.S. taxpayers who held illegal offshore accounts. Investigations into those accounts are ongoing.
Note: For deeply revealing reports from reliable major media sources on the collusion between financial corporations and government regulators, click here.
A federal appeals court blocked San Francisco on [September 10] from requiring cell phone dealers to tell customers the products may expose them to dangerous levels of radiation, saying the city can't force retailers to pass along messages they dispute. The ordinance, the first of its kind in the nation, had been scheduled to take effect last October, but has remained on hold during an industry challenge. It would require retailers to give each cell phone buyer a fact sheet saying the World Health Organization had classified the phones' radio-frequency emissions as a "possible carcinogen." The sheet also shows human silhouettes absorbing radiation and suggests protective measures, like wearing headsets, making shorter calls and limiting use by children. Stores would have to put similar messages on large wall posters and on stickers attached to display ads. The U.S. Supreme Court has ruled that the government can require businesses to display factual, undisputed information about their products. The city's lawyers and policymakers will review the ruling before deciding their next steps.
Note: For deeply revealing reports from reliable major media sources on government corruption, click here.
The U.S. health care system squanders $750 billion a year — roughly 30 cents of every medical dollar — through unneeded care, byzantine paperwork, fraud and other waste, the influential Institute of Medicine [said] in a report. President Barack Obama and Republican Mitt Romney are accusing each other of trying to slash Medicare and put seniors at risk. But the counter-intuitive finding from the report is that deep cuts are possible without rationing, and a leaner system may even produce better quality. More than 18 months in the making, the report identified six major areas of waste: unnecessary services ($210 billion annually); inefficient delivery of care ($130 billion); excess administrative costs ($190 billion); inflated prices ($105 billion); prevention failures ($55 billion), and fraud ($75 billion). Adjusting for some overlap among the categories, the panel settled on an estimate of $750 billion. The report makes ten recommendations, including payment reforms to reward quality results instead of reimbursing for each procedure, improving coordination among different kinds of service providers, leveraging technology to reinforce sound clinical decisions and educating patients to become more savvy consumers. The report’s main message for government is to accelerate payment reforms, said panel chair Dr. Mark Smith, president of the California HealthCare Foundation, a research group. For employers, it’s to move beyond cost shifts to workers and start demanding accountability from hospitals and major medical groups. For doctors, it means getting beyond the bubble of solo practice and collaborating with peers and other clinicians.
Note: The US spends far more on health care than most other developed countries which provide health care to all of their citizens. The US system is driven by profits. For more on this, click here.
The U.S. Justice Department is ramping up its rhetoric against BP [formerly British Petroleum] for the massive 2010 oil spill in the Gulf of Mexico, describing in new court papers examples of what it calls "gross negligence and willful misconduct." The court filing is the sharpest position yet taken by the U.S. government as it seeks to hold the British oil giant largely responsible for the largest oil spill in U.S. history. Gross negligence is a central issue to the case, slated to go to trial in New Orleans in January 2013. A gross negligence finding could nearly quadruple the civil damages owed by BP under the Clean Water Act to $21 billion. The U.S. government and BP are engaged in talks to settle civil and potential criminal liability, though neither side will comment on the status of negotiations. Specifically, errors made by BP and Swiss-based Transocean Ltd, owner of the Deepwater Horizon platform, in deciphering a key pressure test of the Macondo well are a clear indication of gross negligence, the Justice Department said. "That such a simple, yet fundamental and safety-critical test could have been so stunningly, blindingly botched in so many ways, by so many people, demonstrates gross negligence," the government said in its 39-page filing.
Note: For deeply revealing reports from reliable major media sources on corporate corruption, click here.
When the Justice Department recently closed its criminal investigation of Goldman Sachs, it became all but certain that no major American banks or their top executives would ever face criminal charges for their role in the financial crisis. Justice officials and even President Obama have defended the lack of prosecutions, saying that even though greed and other moral lapses were evident in the run-up to the crisis, the conduct was not necessarily illegal. But that characterization of the financial industry's actions has always defied common sense - and all the more so now that a fuller picture is emerging of the range of banks' reckless and lawless activities, including interest-rate rigging, money laundering, securities fraud and excessive speculation. The financial crisis, fomented over years by big banks and presided over by executives, involved reckless lending, heedless securitizations, exorbitant paydays and illusory profits, all of which led to government bailouts and economic calamity. Is it plausible that none of that broke the law and that none of the people in positions of power and authority knew what was going on? The statute of limitations, generally five years for securities fraud and most other federal offenses, is running out, precluding the possibility of bringing many new suits dating from the bubble years. The result is a public perception that the big banks and their leaders will never have to answer fully for the crisis. The shameless pursuit of Wall Street campaign donations by both political parties strengthens this perception, and further undermines confidence in the rule of law.
Note: For deeply revealing reports from reliable major media sources on the collusion between government and the big banks, click here.
In California ... voters will decide in the November election whether consumers should have the right to know what goes in their food. Proposition 37, if it passes, will require food manufacturers to disclose whether their products contain genetically modified organisms (GMO). It is estimated that 40 to 70 percent of foods currently sold in grocery stores in California contain some genetically altered ingredients. The [FDA] does not require safety studies, and no long-term research on potential health effects has been conducted yet, although there are reports of preliminary studies that have linked GMOs to allergies and other health risks. Proposition 37 does not intend to impose any bans. “It’s simply saying: Let’s give consumers information so we can choose for ourselves whether or not we want to eat genetically engineered foods. Consumers in 50 other countries – including all of Europe, Japan, China and Russia – all have this right,” argued Grant Lundberg, the CEO of Lundberg Family Farms, and Kathryn Phillips, Director of the Sierra Club California. Having started as a grassroots movement, Proposition 37 has a good chance of succeeding. A whopping 65 percent of registered voters in California say they support the measure. But so far, less than 3 million dollars have been raised by the organizers. Opponents, mainly chemical and food-processing companies, including Monsanto, BASF, Bayer, Dow, Nestle, Coca Cola and Pepsico, have raised more than nine times as much. Ignoring facts and keeping information secret is not a sustainable strategy in the long run. California’s Right-to-Know movement could morph into something like that with the potential of spreading across the whole country.
Note: This article neglects to mention scientific studies which have shown that lab animals got very sick and some even died after being fed GM food. For a well researched and footnoted paper on this, click here. For a great collection of past major media articles revealing the serious risks and dangers of genetically modified foods, click here.
California voters this fall will decide a ballot measure that would require labeling of foods containing genetically engineered material. But the Department of Agriculture is already tied in knots over how to deal with the contamination of organic and conventional foods by biotech crops. On [August 27], a USDA advisory panel will consider a draft plan to compensate farmers whose crops have been contaminated by pollen, seeds or other stray genetically engineered material. The meeting is expected to be contentious, pitting the biotechnology and organic industries against each other. The draft report acknowledged the difficulty of preventing such material from accidentally entering the food supply and concerns that the purity of traditional seeds may be threatened. It also cited fears on both sides that official action to address contamination could send a signal to U.S. consumers and export markets in Europe, Japan and elsewhere that the purity and even safety of U.S. crops are suspect. Bioengineered crops dominate U.S. commodities, including 90 percent of U.S. corn. In some states, penetration is all but complete, including 99 percent of the Arkansas cotton crop. Most processed foods contain genetically engineered material. The organic industry said biotech companies should be responsible for containing their own genes and that contamination threatens the right of farmers to choose how to farm.
Note: For deeply revealing reports from reliable major media sources on the dangers of genetically-modified foods, click here. For more on the California ballot measure to require GM labelling called the "right to know," click here.
If Proposition 37 passes, California would become the first state in the nation to require new labels on a host of food products commonly found on grocery store shelves. Many other nations, including Japan, China and a host of European countries, already label genetically engineered food. In the United States, however, products that contain genetically engineered ingredients are generally not labeled. Proponents ... have raised $2.8 million. A company owned by Joseph Mercola, a controversial holistic health activist from Illinois with more than 100,000 Twitter followers, has kicked in $800,000. Opponents have raised nine times as much. Almost all of the nearly $25 million has come from a variety of chemical, seed and processed-food companies. Monsanto, a leading producer of genetically engineered seeds, donated $4.2 million, the largest donation. The labeling initiative largely covers processed foods. Milk, cheese and other dairy products made from cows that are injected with the bovine growth hormone or eat genetically engineered feed like alfalfa would be exempt, but meat or dairy products from animals that are genetically engineered would be labeled. In 2000, 25 percent of the corn planted in the United States was genetically engineered, according to the U.S. Department of Agriculture. By 2012, that figure had soared to 88 percent. The group California Right to Know, which is leading the pro-labeling campaign, is counting on a vast social media network and volunteers to get its message out. Stacy Malkan, a spokeswoman for the yes campaign, said [this] "is a people's movement against out-of-state corporations."
Note: A graph in this article shows that 94% of the funds raised against Proposition 37 came from outside of California. And how interesting that Dr. Mercola is called controversial, considering that he now has nearly 2 million subscribers to his mos excellent email list. For an article titled "The Top 10 Lies Told by Monsanto on GMO Labeling in California," click here. For a great collection of past major media articles revealing the serious risks and dangers of genetically modified foods, click here.
Oceana, a group dedicated to preserving the ocean ecosystem, is testing fish nationwide to find out whether seafood fraud is as widespread as some people think it is. It is now possible to determine exactly what species is being served at the local fish shack, thanks to recent advances in genetic sequencing. Oceana has thus far found seafood mislabeling everywhere it has done testing, including Boston, Los Angeles, Miami and Monterey. The DNA-testing campaign, in which dozens of volunteers are provided testing kits with instructions and monitoring sheets, created an uproar when the early results came out. In South Florida ... results showed that 31 percent of the fish tested at restaurants and markets was mislabeled. In Los Angeles, 55 percent, and in Boston, 48 percent of the fish sold was not what it was touted to be. In Los Angeles ... eight out of nine sushi samples labeled as "white tuna," or shiro maguro, were actually escolar, which [has been called] the "ex-lax fish" for its purgative effect on the digestive system. Escolar is not among the 14 species that can legally be labeled as tuna. Oceana found that 87 percent of the sushi venues tested misrepresented the fish being served. The results follow several Consumer Reports studies that had similar results, including a 2006 report that found that 56 percent of the salmon marketed in the United States as wild was actually farmed. Thirty-one percent of grocery stores misidentified fish. In many cases, there is no way for the consumer to know whether the fish is what the restaurant, fish market or grocery store claims it is.
Note: For deeply revealing reports from reliable major media sources on corporate corruption, click here.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.